16
Participants
Start Date
July 23, 2021
Primary Completion Date
November 11, 2022
Study Completion Date
November 11, 2022
Baclofen
Baclofen is the only selective GABA-B agonist licensed for human use. Originally developed as a potential anti-epileptic in the 1920s, it was found to have anti-spastic effects and is currently used for the treatment of spastic movement, especially in instances of spinal cord injury, spastic diplegia, multiple sclerosis, and amyotrophic lateral sclerosis.
Vitamin D3
Placebo tablets will be vitamin D3, (colecalciferol).
Imperial College Healthcare Trust, London
Imperial College London
OTHER